{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:32Z","timestamp":1787027072191,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003408 82003524 82060511"],"award-info":[{"award-number":["82003408 82003524 82060511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Gastric acid suppressants have a major impact on gut microbiome which in turn, may increase the risk of cholelithiasis, but epidemiological evidence remains unclear. We undertook this research to evaluate the association between regular use of proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) with risk of cholelithiasis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Prospective cohort study included 477,293 UK residents aged 37\u201373\u00a0years from the UK Biobank. We included the participants reported PPI or H2RA use, and were free of cholelithiasis or cancer. We evaluated hazard ratios (HRs) of regular use of PPIs or H2RAs and risk of cholelithiasis adjusting for demographic factors, lifestyle habits, the presence of comorbidities, use of other medications, and clinical indications.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    We identified 12,870 cases of cholelithiasis over a median follow-up of 8.1\u00a0years. Regular use of PPIs (HR 1.22 95% CI 1.16\u20131.29) or H2RAs (HR 1.16, 95% CI 1.05\u20131.28) was associated with an increased risk of cholelithiasis after confounding adjustment. There were no major differences among individual PPIs\/H2RAs. The absolute risk of PPI-associated cholelithiasis was increased with the baseline predicted risk evaluated by known environmental and genetic risk factors (Risk differences in the lowest vs. the highest quartile: 1.37 vs. 4.29 per 1,000 person-years).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Regular use of PPIs and H2RAs was associated with increased risk of cholelithiasis. Future prospective studies are required to confirm whether the observed associations are casual.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2021.813587","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:15:50Z","timestamp":1643328950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants"],"prefix":"10.3389","volume":"12","author":[{"given":"Man","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.0953-0673.2003.01721.x","article-title":"The burden of Gallstone Disease in Europe","volume":"18","author":"Aerts","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the Number Needed to Treat for Trials where the Outcome Is Time to an Event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s00464-005-0247-x","article-title":"Proton Pump Inhibitors Reduce Gallbladder Function","volume":"20","author":"Cahan","year":"2006","journal-title":"Surg. Endosc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1136\/gutjnl-2018-316899","article-title":"Proton Pump Inhibitors Increase the Risk of Cholecystitis: a Population-Based Case-Control Study","volume":"68","author":"Chuang","year":"2019","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1007581","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile Salt Hydrolases: Gatekeepers of Bile Acid Metabolism and Host-Microbiome Crosstalk in the Gastrointestinal Tract","volume":"15","author":"Foley","year":"2019","journal-title":"Plos Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12269","DOI":"10.14814\/phy2.12269","article-title":"An Assessment of Human Gastric Fluid Composition as a Function of PPI Usage","volume":"3","author":"Foltz","year":"2015","journal-title":"Physiol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The Risks and Benefits of Long-Term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.1055\/s-0043-102936","article-title":"Proton Pump Inhibitor Is a Risk Factor for Recurrence of Common Bile Duct Stones after Endoscopic Sphincterotomy - Propensity Score Matching Analysis","volume":"5","author":"Fukuba","year":"2017","journal-title":"Endosc. Int. Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1136\/gutjnl-2020-323816","article-title":"Risk Stratification for Proton Pump Inhibitor-Associated Type 2 Diabetes: a Population-Based Cohort Study","volume":"70","author":"He","year":"2020","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.14309\/ajg.0000000000001377","article-title":"No Associations between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-specific Mortality: A Population-Based Cohort of 0.44 Million Participants","volume":"116","author":"He","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CLEP.S37357","article-title":"Gallbladder Cancer: Epidemiology and Outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton Pump Inhibitors Affect the Gut Microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2016.04.007","article-title":"Four Susceptibility Loci for Gallstone Disease Identified in a Meta-Analysis of Genome-wide Association Studies","volume":"151","author":"Joshi","year":"2016","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4161\/19490976.2014.969986","article-title":"Bacterial Bile Salt Hydrolase in Host Metabolism: Potential for Influencing Gastrointestinal Microbe-Host Crosstalk","volume":"5","author":"Joyce","year":"2014","journal-title":"Gut Microbes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/hep.31914","article-title":"Association between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: a Swedish Population-Based Cohort Study","volume":"74","author":"Kamal","year":"2021","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00534-006-1152-y","article-title":"Definitions, Pathophysiology, and Epidemiology of Acute Cholangitis and Cholecystitis: Tokyo Guidelines","volume":"14","author":"Kimura","year":"2007","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/apt.15466","article-title":"Use of Proton Pump Inhibitors and the Risk of Cholangitis: a Nationwide Cohort Study","volume":"50","author":"Min","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40168-019-0712-8","article-title":"The Human Gallbladder Microbiome Is Related to the Physiological State and the Biliary Metabolic Profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"B20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/aje\/kwt322","article-title":"Gallstones, Cholecystectomy, and Risk of Digestive System Cancers","volume":"179","author":"Nogueira","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SGA.0000000000000235","article-title":"Risk Factors for Cholelithiasis","volume":"39","author":"Pak","year":"2016","journal-title":"Gastroenterol. Nurs."},{"key":"B22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/gast.1996.v111.pm8780583","article-title":"Gallbladder Emptying and Gallstone Formation: a Prospective Study on Gallstone Recurrence","volume":"111","author":"Pauletzki","year":"1996","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3109\/00365529709011199","article-title":"A Double-Blind Placebo-Controlled Study on the Effects of Omeprazole on Gut Hormone Secretion and Gastric Emptying Rate","volume":"32","author":"Rasmussen","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age","volume":"12","author":"Sudlow","year":"2015","journal-title":"Plos Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: Introducing the E-Value","volume":"167","author":"Vanderweele","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12876-020-01195-1","article-title":"Intestinal flora Imbalance Affects Bile Acid Metabolism and Is Associated with Gallstone Formation","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut Microbiota Dysbiosis and Bacterial Community Assembly Associated with Cholesterol Gallstones in Large-Scale Study","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1053\/j.gastro.2021.08.005","article-title":"Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts","volume":"161","author":"Xia","year":"2021","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1136\/gutjnl-2020-321052","article-title":"Proton Pump Inhibitors and the Risk of Gallbladder Cancer: a Hospital-Based Case-Control Study","volume":"69","author":"Xiong","year":"2020","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41598-020-57612-8","article-title":"Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12916-021-02180-5","article-title":"Regular Use of Proton-Pump Inhibitors and Risk of Stroke: a Population-Based Cohort Study and Meta-Analysis of Randomized-Controlled Trials","volume":"19","author":"Yang","year":"2021","journal-title":"BMC Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/apt.15834","article-title":"Regular Use of Proton Pump Inhibitor and Risk of Rheumatoid Arthritis in Women: a Prospective Cohort Study","volume":"52","author":"Yuan","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/gutjnl-2020-322557","article-title":"Regular Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results from Three Prospective Cohort Studies","volume":"70","author":"Yuan J","year":"2021","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.12.034","article-title":"Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation","author":"Yuan S","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.813587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:15:53Z","timestamp":1643328953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.813587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":34,"alternative-id":["10.3389\/fphar.2021.813587"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.813587","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"article-number":"813587"}}